Fact CheckerSign in

NCT03958747Completed

Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy

A Pilot Study Using Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy

Source: ClinicalTrials.gov · Last updated 21 Jul 2026

Brief summary (registry, in English)

This pilot clinical trial studies how well ultrasound works in detecting oxaliplatin-induced neuropathy in participants with gastrointestinal cancer. Ultrasound may work better in diagnosing and detecting neuropathy in gastrointestinal cancer participants treated with the chemotherapy drug called oxaliplatin.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
17 May 2019
Start date
17 Dec 2019
Primary completion date
26 Nov 2025
Lead sponsor
Wake Forest University Health Sciences
NCT number
NCT03958747

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 17 Dec 2019 to the primary completion date, 26 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Self-reported or documented history of pre-existing peripheral neuropathy prior to initiation of oxaliplatin chemotherapy.

Other

  • Unable to provide history.

Who the study is looking for

  • Any gastrointestinal cancer including colon, rectal, colorectal, pancreas, esophageal, or other (any stage)
  • Previously or currently receiving oxaliplatin -based chemotherapy.
  • Clinical symptoms of peripheral neuropathy noted in medical record and suspected to be secondary to oxaliplatin -based therapy.
  • Ability and willingness to understand and sign an informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Wake Forest Baptist Comprehensive Cancer Center
Coordinator of this site? Confirm its status
Winston-SalemUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.